← Back to Search

Cognitive Support Technology for Autism

N/A
Waitlist Available
Research Sponsored by Kent State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have a clinical diagnosis of Autism Spectrum Disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (enrollment in study), 6 months, and 1 year (study completion)
Awards & highlights

Summary

This trial will help fill important gaps in knowledge about how to best help people with ASD transition from postsecondary education to employment.

Who is the study for?
This trial is for post-secondary students within a 60-mile radius of Kent, Ohio who have been clinically diagnosed with Autism Spectrum Disorder (ASD). It's designed to help these students transition from education to employment.
What is being tested?
The study tests Cognitive Support Technology (CST) that combines assistive technology and vocational rehabilitation practices. The goal is to improve academic success and career readiness for students with ASD.
What are the potential side effects?
Since the intervention involves educational support technology, risks are minimal and similar to everyday life. There may be no direct medical side effects, but support will be provided if psychological distress arises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Autism Spectrum Disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (enrollment in study), 6 months, and 1 year (study completion)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (enrollment in study), 6 months, and 1 year (study completion) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Grade Point Average (GPA)
Secondary study objectives
% of Participants Receiving Disability Benefits
Acceptance of Disability
Current Employment Status
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Full TreatmentExperimental Treatment1 Intervention
Steps of the Intervention Condition. Following an in-person session in which a pretest assessment is completed, each member of the intervention group will participate in three face-to-face sessions with the interventionist at the student's campus or at the interventionist's office to complete the CST component of the intervention. Taking into consideration available psychoeducational assessment data, functional assessments from other agencies, and the participant's self-report regarding the functional difficulties that result from his or her ASD-related cognitive impairments, Scherer's (2012) Matching Person and Technology (MPT) protocol will guide the CST assessment. For purposes of the CST component of this intervention, the technological platform for cognitive accommodations will be an iPad II that is provided to each intervention-group participant at no charge (including wireless access if needed). The interventionist will provide training in the use of the iPad if necessary.
Group II: Abbreviated TreatmentActive Control1 Intervention
Steps of the Control Condition. Following an in-person session in which the pretest assessment is completed, each member of the control group will participate in two telephone or Skype sessions with the interventionist to discuss her or his needs for electronic cognitive supports. An abbreviated version of Scherer's (2012) MPT assessment will be administered via telephone or Skype in the first of these virtually-administered sessions. In the second telephone or Skype session, the interventionist will summarize the results of the abbreviated MPT assessment, suggest a variety of cognitive enhancement apps for tablet computers or smart phones that the control group participant can consider.

Find a Location

Who is running the clinical trial?

Kent State UniversityLead Sponsor
43 Previous Clinical Trials
6,799 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
710 Previous Clinical Trials
22,886,847 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
259 Patients Enrolled for Autism Spectrum Disorder

Media Library

Cognitive Support Technology (CST) Clinical Trial Eligibility Overview. Trial Name: NCT04980963 — N/A
Autism Spectrum Disorder Research Study Groups: Full Treatment, Abbreviated Treatment
Autism Spectrum Disorder Clinical Trial 2023: Cognitive Support Technology (CST) Highlights & Side Effects. Trial Name: NCT04980963 — N/A
Cognitive Support Technology (CST) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04980963 — N/A
~16 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top